HomeJSPR • NASDAQ
add
Jasper Therapeutics Inc
Previous close
$4.23
Day range
$3.95 - $4.30
Year range
$3.14 - $26.84
Market cap
60.61M USD
Avg Volume
211.16K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 25.28M | 42.65% |
Net income | -24.32M | -46.68% |
Net profit margin | — | — |
Earnings per share | -1.62 | -7.73% |
EBITDA | -25.04M | -43.56% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 71.64M | -17.55% |
Total assets | 79.90M | -15.80% |
Total liabilities | 18.22M | 10.78% |
Total equity | 61.67M | — |
Shares outstanding | 15.02M | — |
Price to book | 1.03 | — |
Return on assets | -70.51% | — |
Return on capital | -84.71% | — |
Cash Flow
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -24.32M | -46.68% |
Cash from operations | -21.13M | -28.25% |
Cash from investing | -76.00K | 66.96% |
Cash from financing | 345.00K | 227.31% |
Net change in cash | -20.86M | -22.88% |
Free cash flow | -12.81M | -26.47% |
About
Founded
2019
Headquarters
Website
Employees
64